← Scroll for more →
Financial Statements — LABT
Balance Sheet
(in millions USD)| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q1 2025 | Q4 2024 | Q4 2023 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 2.58 | 0.01 | 0.24 | -- | 0.68 | 2.53 |
| Short-term Investments | 2.00 | -- | -- | -- | -- | -- |
| Total Current Assets | 4.85 | 0.05 | 0.31 | -- | 0.77 | -- |
| Property, Plant & Equipment | 0.01 | 0.01 | 0.01 | -- | 0.01 | -- |
| Total Non-current Assets* | 0.11 | 0.15 | 0.18 | -- | 0.30 | -- |
| Total Assets | 4.96 | 0.20 | 0.48 | -- | 1.07 | -- |
| Accounts Payable | 0.17 | 0.55 | 0.38 | -- | 0.17 | -- |
| Total Current Liabilities | 0.63 | 3.03 | 2.41 | -- | 0.50 | -- |
| Total Non-current Liabilities* | 0.00 | 0.01 | 0.04 | -- | 0.16 | -- |
| Total Liabilities | 0.63 | 3.04 | 2.45 | -- | 0.66 | -- |
| Retained Earnings | (68.64) | (54.27) | (53.35) | -- | (49.50) | -- |
| Total Stockholder Equity | 4.33 | (2.84) | (1.96) | (0.08) | 0.41 | 4.56 |
← Scroll for more columns →
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|
| Cost of Revenue | -- | 0.51 | -- | -- |
| Research & Development | 0.50 | 0.18 | 0.15 | -- |
| Selling, General & Admin | 3.29 | 0.70 | 0.49 | -- |
| Total Operating Expenses | 3.79 | 0.89 | 0.64 | -- |
| Operating Income | (3.79) | (0.89) | (0.64) | -- |
| Net Income | (3.77) | (0.92) | (0.66) | (0.54) |
| Basic EPS | (2.75) | (0.20) | (1.66) | -- |
| Diluted EPS | (2.75) | (0.20) | (1.66) | -- |
← Scroll for more columns →
Cash Flow Statement
(in millions USD)| Metric | Q2 2026 | Q1 2026 |
|---|---|---|
| Operating Cash Flow | (2.10) | (0.35) |
| Investing Cash Flow | (2.00) | -- |
| Financing Cash Flow | 6.68 | 0.13 |
← Scroll for more columns →